Crestline Management, LP - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 205 filers reported holding HERON THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
Crestline Management, LP ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$1,696,000
+54.3%
185,766
+80.6%
0.13%
+23.3%
Q3 2021$1,099,000
-62.6%
102,845
+36.0%
0.10%
-66.7%
Q2 2018$2,939,000
+17.1%
75,645
-16.8%
0.31%
-1.0%
Q1 2018$2,509,000
+19.2%
90,916
-21.8%
0.31%
+44.4%
Q4 2017$2,105,000
+225.3%
116,290
+190.2%
0.22%
+140.0%
Q3 2017$647,000
+26.1%
40,078
+8.3%
0.09%
+30.4%
Q2 2017$513,00037,0200.07%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders